Health
Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada – Motley Fool Australia
Health Canada will determine BNT162b2’s suitability for approval as clinical trial data comes in.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The coronavirus vaccine candidate being developed by Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country’s healthcare regulatory authority.
A rolling review is one undertaken while a candidate is still in developme…
-
Business24 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Business23 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News23 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Noosa News23 hours agoDid AI write your accounting expert’s report? – Proctor